Patients being treated with dual-antiplatelet therapy (DAPT) consisting of clopidogrel plus aspirin following atrial septal defect (ASD) closure can safely discontinue clopidogrel after 3 months ...
New-onset migraine attacks affect approximately 15% of patients undergoing transcatheter atrial septal defect (ASD) closure. Findings from the CANOA trial, presented at the AHA Scientific Sessions ...
Tawam Hospital, the UAE and Gulf region's premier healthcare provider, organised an interventional cardiology workshop, in the period from 12-16 November, 2006. Dr Michael Slack, an internationally ...
Patients undergoing transcatheter atrial septal defect (ASD) closure did not have worsening migraines after completing a course of dual antiplatelet therapy, the CANOA investigators found. Overall, ...
Long-term survival after transcatheter closure of secundum atrial septal defects (ASD) is similar to that achieved after surgical closure, but the former method is far more likely to require ...
ORLANDO, FL—Three months of clopidogrel on top of aspirin appears to reduce the number and severity of migraines following atrial septal defect (ASD) closure, a new study suggests. The findings, while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback